Clinical Trials Browser

Phase 2/3 × Lymphoma, Large B-Cell, Diffuse × Tamoxifen × Clear all

NCT06355401 2024-04-09

Maintenance Hormonal Therapy and DLBCL

Phase 2/3 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse